NCT01450111View on ClinicalTrials.gov

To Evaluate the Pharmacokinetics and Safety/Tolerability of Lacosamide in 3 Dosages in Healthy Male Korean Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Epilepsy
Interventions
DRUG

Lacosamide

Lacosamide 50 mg, tablet, once in the morning on Day 1

DRUG

Lacosamide

Lacosamide 100 mg, tablet, once in the morning on Day 1 Lacosamide 100 mg, tablet, twice daily Day 5 to Day 8 and once in the morning on Day 9

DRUG

Lacosamide

Lacosamide 200 mg, tablet, once in the morning on Day 1 Lacosamide 200 mg, tablet, twice daily Day 5 to Day 8 and once in the morning on Day 9

OTHER

Placebo

Placebo matched with Lacosamide 50 mg tablet once in the morning on day 1.

OTHER

Placebo

Placebo matched with Lacosamide 100 mg, tablet, once in the morning on Day 1 Placebo matched with Lacosamode 100 mg, tablet, twice daily Day 5 to Day 8 and once in the morning on Day 9

OTHER

Placebo

Placebo matched with Lacosamide 200 mg, tablet, once in the morning on Day 1 Placebo matched with Lacosamide 200 mg, tablet, twice daily Day 5 to Day 8 and once in the morning on Day 9

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY